Skip to main content
Erschienen in: Acta Diabetologica 1/2011

01.03.2011 | Original Article

Blood glucose monitoring in the normal population: the PREDICA study

verfasst von: N. Napoli, F. Costanza, E. Di Stasio, R. Strollo, S. Manfrini, E. Cipponeri, A. Picardi, F. Carrano, V. Dell’Anna, W. Macino, P. Pozzilli

Erschienen in: Acta Diabetologica | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

In the PREdiction of DIabetes from CApillary blood glucose (PREDICA) study, we propose a novel approach based on multiple capillary blood glucose (CBG) measurements, assuming that weekly measurements performed for 2 months may be an efficient strategy to screen for diabetes. We studied 538 Caucasian subjects (247 men and 291 women) without a history of diabetes, consecutively recruited by 50 GPs from the Italian provinces of Rome and Frosinone. Subjects were asked to perform 8 fasting glucose and 8 post-prandial glucose measurements during a frame time of 2 months (Glucometer Accu-chek AVIVA Roche Diagnostics). Study subjects were 55 ± 9 years old (range 22–77 years of age), 50% were overweight and 16% obese. Fifty-eight percent of subjects have performed 13 to 16 CBG measurements during the study, 68% of subjects have performed at least 5 out of 8, both fasting and post-prandial measurements. Among 492 subjects who had at least two fasting measurements, 63.6% had normal glucose levels, 25.4% showed IFG, and 11.0% were diabetic. Considering post-prandial measurements, 74.2% had normal glucose levels, 23.0% had IGT, and 2.8% were diabetic. Combined IFG + IGT was detected in 7% of study subjects, while in 0.8% diagnosis of diabetes was confirmed with both fasting and post-prandial measurements. In this study, we found a high adherence to a novel screening strategy based on self-glucose monitoring in the general population. Our results show that multiple CBG measurements may represent a simple and efficient method for diabetes screening.
Literatur
1.
Zurück zum Zitat Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006) Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care 29:2114–2116PubMedCrossRef Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006) Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care 29:2114–2116PubMedCrossRef
2.
Zurück zum Zitat Giugliano D, Standl E, Vilsbøll T, Betteridge J, Bonadonna R, Campbell IW, Schernthaner GH, Staels B, Trichopoulou A, Farinaro E (2009) Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? Acta Diabetol 46(3):173–181PubMedCrossRef Giugliano D, Standl E, Vilsbøll T, Betteridge J, Bonadonna R, Campbell IW, Schernthaner GH, Staels B, Trichopoulou A, Farinaro E (2009) Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? Acta Diabetol 46(3):173–181PubMedCrossRef
3.
Zurück zum Zitat Nádas J, Putz Z, Fövényi J, Gaál Z, Gyimesi A, Hídvégi T, Hosszúfalusi N, Neuwirth G, Oroszlán T, Pánczél P, Vándorfi G, Winkler G, Wittmann I, Jermendy G (2009) Cardiometabolic risk and educational level in adult patients with type 1 diabetes. Acta Diabetol 46(2):159–162PubMedCrossRef Nádas J, Putz Z, Fövényi J, Gaál Z, Gyimesi A, Hídvégi T, Hosszúfalusi N, Neuwirth G, Oroszlán T, Pánczél P, Vándorfi G, Winkler G, Wittmann I, Jermendy G (2009) Cardiometabolic risk and educational level in adult patients with type 1 diabetes. Acta Diabetol 46(2):159–162PubMedCrossRef
4.
Zurück zum Zitat Atkins RC, Zimmet P (2010) Diabetic kidney disease: act now or pay later. Acta Diabetol 47(1):1–4PubMedCrossRef Atkins RC, Zimmet P (2010) Diabetic kidney disease: act now or pay later. Acta Diabetol 47(1):1–4PubMedCrossRef
5.
Zurück zum Zitat Greco D, Gambina F, Maggio F (2009) Ophthalmoplegia in diabetes mellitus: a retrospective study. Acta Diabetol 46(1):23–26PubMedCrossRef Greco D, Gambina F, Maggio F (2009) Ophthalmoplegia in diabetes mellitus: a retrospective study. Acta Diabetol 46(1):23–26PubMedCrossRef
7.
Zurück zum Zitat Aroda VR, Ratner R (2008) Approach to the patient with prediabetes. J Clin Endocrinol Metab 93:3259–3265PubMedCrossRef Aroda VR, Ratner R (2008) Approach to the patient with prediabetes. J Clin Endocrinol Metab 93:3259–3265PubMedCrossRef
8.
Zurück zum Zitat Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef
9.
Zurück zum Zitat Levitan EB, Song Y, Ford ES, Liu S (2004) Is non diabetic hyperglycaemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef Levitan EB, Song Y, Ford ES, Liu S (2004) Is non diabetic hyperglycaemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef
10.
Zurück zum Zitat Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
11.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
12.
Zurück zum Zitat Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 29:1263–1268PubMedCrossRef Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 29:1263–1268PubMedCrossRef
13.
Zurück zum Zitat Diabetes Prevention Program Research Group (2007) The prevalence of rethinopaty in impaired glucose tolerance in the Diabetes Prevention Program. Diabet Med 24:137–144CrossRef Diabetes Prevention Program Research Group (2007) The prevalence of rethinopaty in impaired glucose tolerance in the Diabetes Prevention Program. Diabet Med 24:137–144CrossRef
14.
Zurück zum Zitat Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819PubMedCrossRef Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819PubMedCrossRef
15.
Zurück zum Zitat Norris SL, Kansagara D, Bougatsos C, Fu R (2008) Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Int Med 148:855–868PubMed Norris SL, Kansagara D, Bougatsos C, Fu R (2008) Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Int Med 148:855–868PubMed
16.
Zurück zum Zitat American Diabetes Association (2008) Standards of medical care in diabetes–2008. Diabetes Care 31(suppl 1):S12–S54CrossRef American Diabetes Association (2008) Standards of medical care in diabetes–2008. Diabetes Care 31(suppl 1):S12–S54CrossRef
17.
Zurück zum Zitat Puavilai G, Kheesukapan P, Chanprasertyotin S, Chantraraprasert S, Suwanvilaikorn S, Nitiyanant W, Deerochochanawong C, Benjasuratwong Y, Munsakul N, Pongchaiyaikul C, Kespechara K, Montreewasuwat N (2001) Random capillary plasma glucose measurement in the screening of diabetes mellitus in high-risk subjects in Thailand. Diabetes Res Clin Pract 51:125–131PubMedCrossRef Puavilai G, Kheesukapan P, Chanprasertyotin S, Chantraraprasert S, Suwanvilaikorn S, Nitiyanant W, Deerochochanawong C, Benjasuratwong Y, Munsakul N, Pongchaiyaikul C, Kespechara K, Montreewasuwat N (2001) Random capillary plasma glucose measurement in the screening of diabetes mellitus in high-risk subjects in Thailand. Diabetes Res Clin Pract 51:125–131PubMedCrossRef
18.
Zurück zum Zitat Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef
20.
Zurück zum Zitat Sheeny AM, Coursin DB, Gabbay RA (2009) Back to Wilson and Jungner:10 Good reasons to screen for type 2 diabetes mellitus. Mayo Clin Proc 84:38–42CrossRef Sheeny AM, Coursin DB, Gabbay RA (2009) Back to Wilson and Jungner:10 Good reasons to screen for type 2 diabetes mellitus. Mayo Clin Proc 84:38–42CrossRef
21.
Zurück zum Zitat Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM (2003) Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care 26:2536–2542PubMedCrossRef Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM (2003) Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care 26:2536–2542PubMedCrossRef
22.
Zurück zum Zitat Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H (2000) Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Daibetes Res Clin Pract 49:181–186CrossRef Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H (2000) Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Daibetes Res Clin Pract 49:181–186CrossRef
23.
Zurück zum Zitat Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM (2001) Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899–1903PubMedCrossRef Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM (2001) Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899–1903PubMedCrossRef
24.
Zurück zum Zitat Monnier L, Colette C, Dunseath GJ, Owens DR (2007) The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30:263–269PubMedCrossRef Monnier L, Colette C, Dunseath GJ, Owens DR (2007) The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30:263–269PubMedCrossRef
25.
Zurück zum Zitat Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19:708–723PubMedCrossRef Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19:708–723PubMedCrossRef
26.
Zurück zum Zitat Larson-Cohn U (1976) Differences between capillary and venous blood glucose during oral glucose tolerance test. Scand J Clin Lab Invest 36:805–808CrossRef Larson-Cohn U (1976) Differences between capillary and venous blood glucose during oral glucose tolerance test. Scand J Clin Lab Invest 36:805–808CrossRef
27.
Zurück zum Zitat Eriksson KF, Fex G, Trell E (1983) Capillary-venous differences in blood glucose values during the oral glucose tolerance test. Clin Chem 29(5):993PubMed Eriksson KF, Fex G, Trell E (1983) Capillary-venous differences in blood glucose values during the oral glucose tolerance test. Clin Chem 29(5):993PubMed
28.
Zurück zum Zitat Kuwa K, Nakayama T, Hoshino T, Tominaga M (2001) Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 307:187–192PubMedCrossRef Kuwa K, Nakayama T, Hoshino T, Tominaga M (2001) Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 307:187–192PubMedCrossRef
29.
Zurück zum Zitat Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M (2004) Bruneck study. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53(7):1782–1789PubMedCrossRef Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M (2004) Bruneck study. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53(7):1782–1789PubMedCrossRef
30.
Zurück zum Zitat Kruijshoop M, Feskens EJ, Blaak EE, de Bruin TW (2004) Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clin Chim Acta 341(1–2):33–40PubMedCrossRef Kruijshoop M, Feskens EJ, Blaak EE, de Bruin TW (2004) Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clin Chim Acta 341(1–2):33–40PubMedCrossRef
31.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79PubMedCrossRef Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79PubMedCrossRef
32.
33.
Zurück zum Zitat Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E (2006) DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29:1619–1625PubMedCrossRef Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E (2006) DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29:1619–1625PubMedCrossRef
34.
Zurück zum Zitat Dankner R, Geulayov G, Olmer L, Kaplan G (2009) Undetected type 2 diabetes in older adults. Age Ageing 38:56–62PubMedCrossRef Dankner R, Geulayov G, Olmer L, Kaplan G (2009) Undetected type 2 diabetes in older adults. Age Ageing 38:56–62PubMedCrossRef
Metadaten
Titel
Blood glucose monitoring in the normal population: the PREDICA study
verfasst von
N. Napoli
F. Costanza
E. Di Stasio
R. Strollo
S. Manfrini
E. Cipponeri
A. Picardi
F. Carrano
V. Dell’Anna
W. Macino
P. Pozzilli
Publikationsdatum
01.03.2011
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2011
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0212-6

Weitere Artikel der Ausgabe 1/2011

Acta Diabetologica 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.